Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04601064 · ClinicalTrials.gov registry record · NA

Peer Supported Collaborative Care Mental Health and Substance Use Disorder Care

A NA study of HIV Infections and Opioid Use, sponsored by Johns Hopkins University.

Active
Registry status
NA
Development phase
405
Enrollment target
1
Study location

NCT04601064: Active NA study of HIV Infections and Opioid Use, sponsored by Johns Hopkins University.

NCT04601064 is a NA study of HIV Infections and Opioid Use that is active but no longer recruiting, run by Johns Hopkins University. The registered enrollment target is 405 participants, roughly in line with the 445-participant average among 542 other HIV Infections trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04601064, a NA study of HIV Infections and Opioid Use, is active but no longer recruiting, sponsored by Johns Hopkins University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
405 participants
Enrollment target
1
Study location

Study Summary

This is a research study to assess the effectiveness of a peer-led collaborative care model for integrating treatment for substance use and or mental health disorders into HIV care settings. Depending on whether or not participants enroll in this study, participants will be assigned randomly (by chance, like drawing a number from a hat) to one of two groups. In group 1, participants would receive usual clinical care. In group 2, participants would work with a peer-case manager who would help support participants to engage in substance use or mental health disorder care. Regardless of the group participants are in, participants will fill out a survey when first enrolled in the study, and then again 12 months later.

Primary Outcome

This is defined as a viral load \< 200 copies/ml

Conditions Studied

HIV Infections Opioid Use Substance Use Disorders Drug Use Addiction Mental Health Disorder

Interventions

  • BEHAVIORAL Collaborative Care Model

Study Locations (1)

Maryland

  • Johns Hopkins Hospital - Baltimore

Trial Details

FieldValue
Enrollment Target 405 participants
Start Date 2022-04-20
Est. Completion 2026-12-15
Phase NA
Johns Hopkins University

1,448 total trials

What the registry record for NCT04601064 still lists

NCT04601064 is an interventional study that assigns participants to a tested intervention. The registered 405 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 445-participant average among 542 other HIV Infections trials with a reported enrollment target.

The record links to 6 conditions, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Collaborative Care Model is the first listed.

NCT04601064 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT04601064 about?

NCT04601064 is a clinical study titled "Peer Supported Collaborative Care Mental Health and Substance Use Disorder Care". This is a research study to assess the effectiveness of a peer-led collaborative care model for integrating treatment for substance use and or mental health disorders into HIV care settings. Depending on whether or not participants enroll in this study, participants will be assigned randomly (by ch...

What is the current status of trial NCT04601064?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 405 participants. The study started on 2022-04-20. Estimated completion is 2026-12-15.

What conditions does trial NCT04601064 study?

This clinical trial studies the following conditions: HIV Infections, Opioid Use, Substance Use Disorders, Drug Use, Addiction.

What interventions are being tested in trial NCT04601064?

The interventions under investigation include: Collaborative Care Model (BEHAVIORAL).

Who is sponsoring clinical trial NCT04601064?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04601064 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04601064's enrollment target sits among peer trials

405 78th of 542 higher than 464 of 542 other HIV Infections trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07066657 · 405 participants · Phase 1

    A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

  • NCT06223360 · 406 participants · Phase 2

    A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)

  • NCT06411769 · 406 participants · NA

    Evidence-based Intervention to Improve Walking Engagement in El Paso, Texas

  • NCT06585787 · 406 participants · Phase 3

    A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT04601064, the US trial registry maintained by the National Library of Medicine. NCT04601064 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.